These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 2327475

  • 1. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
    Sun XM, Hsueh W, Torre-Amione G.
    Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475
    [Abstract] [Full Text] [Related]

  • 2. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW.
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [Abstract] [Full Text] [Related]

  • 3. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
    Sun XM, Hsueh W.
    J Immunol; 1991 Jul 15; 147(2):509-14. PubMed ID: 2071893
    [Abstract] [Full Text] [Related]

  • 4. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
    Li SH, Fei X, Gong XQ, Wu ZL.
    Yao Xue Xue Bao; 1991 Jul 15; 26(1):6-9. PubMed ID: 1887797
    [Abstract] [Full Text] [Related]

  • 5. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Oct 15; 255(1):256-63. PubMed ID: 2213560
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO, Letts G, Meade CJ.
    J Lipid Mediat; 1990 Oct 15; 2 Suppl():S101-8. PubMed ID: 2133276
    [Abstract] [Full Text] [Related]

  • 7. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
    Squadrito F, Ioculano M, Altavilla D, Zingarelli B, Canale P, Campo GM, Saitta A, Calapai G, Bussolino F, Caputi AP.
    J Lipid Mediat; 1993 Aug 15; 8(1):53-65. PubMed ID: 8257777
    [Abstract] [Full Text] [Related]

  • 8. RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.
    Floch A, Bousseau A, Hetier E, Floc'h F, Bost PE, Cavero I.
    J Lipid Mediat; 1989 Aug 15; 1(6):349-60. PubMed ID: 2519903
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies.
    Fernández-Gallardo S, Ortega MP, Priego JG, de Casa-Juana MF, Sunkel C, Sánchez Crespo M.
    J Pharmacol Exp Ther; 1990 Oct 15; 255(1):34-9. PubMed ID: 2170626
    [Abstract] [Full Text] [Related]

  • 10. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD, Mikulaschek AW.
    Circ Shock; 1986 Oct 15; 20(3):193-203. PubMed ID: 3802423
    [Abstract] [Full Text] [Related]

  • 11. The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model.
    Engelberts I, von Asmuth EJ, van der Linden CJ, Buurman WA.
    Lymphokine Cytokine Res; 1991 Apr 15; 10(1-2):127-31. PubMed ID: 1873355
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D, Squadrito F, Serrano M, Campo GM, Squadrito G, Arlotta M, Urna G, Sardella A, Saitta A, Caputi AP.
    Br J Pharmacol; 1998 Jul 15; 124(6):1293-9. PubMed ID: 9720803
    [Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver.
    Huang L, Tan X, Crawford SE, Hsueh W.
    Immunology; 1994 Sep 15; 83(1):65-9. PubMed ID: 7821968
    [Abstract] [Full Text] [Related]

  • 14. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B, van der Poll T, Levi M, van Deventer SJ, ten Cate H, Imai Y, Hack CE, ten Cate JW.
    J Immunol; 1994 Mar 01; 152(5):2438-46. PubMed ID: 8133055
    [Abstract] [Full Text] [Related]

  • 15. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M, Jones SB.
    Circ Shock; 1990 Oct 01; 32(2):153-63. PubMed ID: 2253318
    [Abstract] [Full Text] [Related]

  • 16. Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Macari DM, Teixeira MM, Hellewell PG.
    J Immunol; 1996 Aug 15; 157(4):1684-92. PubMed ID: 8759756
    [Abstract] [Full Text] [Related]

  • 17. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
    Rabinovici R, Esser KM, Lysko PG, Yue TL, Griswold DE, Hillegass LM, Bugelski PJ, Hallenbeck JM, Feuerstein G.
    Circ Res; 1991 Jul 15; 69(1):12-25. PubMed ID: 1647275
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F, Decker K.
    Eur Cytokine Netw; 1994 Jul 15; 5(3):311-7. PubMed ID: 7948767
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
    Lang CH, Dobrescu C, Hargrove DM, Bagby GJ, Spitzer JJ.
    Circ Shock; 1987 Jul 15; 23(3):179-88. PubMed ID: 3427772
    [Abstract] [Full Text] [Related]

  • 20. Dissociation of TNF-alpha from endotoxin-induced nitric oxide and acute-phase hypotension.
    Xie J, Joseph KO, Bagby GJ, Giles TD, Greenberg SS.
    Am J Physiol; 1997 Jul 15; 273(1 Pt 2):H164-74. PubMed ID: 9249487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.